The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
158 - If the product trademark has changed from T to R, can the Sponsor change a previously PAAB approved material to reflect this trademark change without re-submitting to PAAB?
FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1
Posts
1
Posters
279
Views
1
Watching
-
Yes. Review of this change would not be required. We ask that the updated APS be sent to review@paab.ca as an FYI. It is important that the PAAB has the current version of the APS on file. Please call Laurie or Sabrina if you have any questions regarding FYIs.
